Christopher B. Caldwell, M.D.

Dr. Christopher Caldwell is highly regarded throughout Greater Rochester for his extensive surgical expertise and on-going efforts to bring state-of-the-art treatments and techniques to benefit patients with cancer.

He is skilled at performing numerous surgical procedures. As a surgical oncologist, he has a particular interest in treatments related to breast cancer, breast disease, melanoma, and other cancers. He was the first surgeon in the area to introduce sentinel node technology, and is the principal investigator in Rochester for the National Surgical Adjuvant Breast and Bowel Project (NSABP), a cooperative research group. A recent study demonstrated the value of using Tamoxifen to prevent breast cancer.

Dr. Caldwell received a B.S. in chemistry and biology in 1978 from Bowdoin College, graduating summa cum laude and Phi Beta Kappa. He earned his medical degree in 1982 from the University of Vermont College of Medicine.

While completing his surgical residency at the University of Rochester Medical Center he was awarded an outstanding resident award at Highland Hospital, an excellence-in-teaching award at Strong Memorial Hospital, and a resident research award from the Association for Academic Surgery. He later completed a year-long fellowship in surgery at Cornell University Medical Center, and a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center.

Dr. Caldwell is certified by the American Board of Surgery and is a Diplomat of the National Board of Medical Examiners. He is a Clinical Assistant Professor of surgery at the University of Rochester School of Medicine and Dentistry.

He is a frequent presenter to patient and community organizations on topics related to breast cancer. Dr. Caldwell also has co-authored research papers, and contributed chapters in medical books related to his specialty area.